Company Analysis BioPharma Credit PLC
1. Summary
Advantages
- Price (0.813 $) is less than fair price (0.8904 $)
- Dividends (4.6%) are higher than the sector average (0%).
Disadvantages
- The stock's return over the last year (-12.67%) is lower than the sector average (37.65%).
- The company's current efficiency (ROE=0%) is lower than the sector average (ROE=0%)
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| BioPharma Credit PLC | Index | ||
|---|---|---|---|
| 7 days | 0% | -0.2% | -2.2% |
| 90 days | -7.1% | -1.9% | -3.7% |
| 1 year | -12.7% | 37.6% | 13.4% |
BOPCF vs Sector: BioPharma Credit PLC has significantly underperformed the "" sector by -50.32% over the past year.
BOPCF vs Market: BioPharma Credit PLC has significantly underperformed the market by -26.04% over the past year.
Stable price: BOPCF is not significantly more volatile than the rest of the market on "USA Stocks" over the last 3 months, with typical variations of +/- 5% per week.
Long period: BOPCF with weekly volatility of -0.2437% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (0.813 $) is lower than the fair price (0.8904 $).
Price not significantly lower than the fair price: The current price (0.813 $) is slightly lower than the fair price by 9.5%.
4.2. P/E
P/E vs Sector: The company's P/E (0) is higher than that of the sector as a whole (0).
P/E vs Market: The company's P/E (0) is higher than that of the market as a whole (0).
4.3. P/BV
P/BV vs Sector: The company's P/BV (0) is higher than that of the sector as a whole (0).
P/BV vs Market: The company's P/BV (0) is higher than that of the market as a whole (0).
4.4. P/S
P/S vs Sector: The company's P/S indicator (0) is higher than that of the sector as a whole (0).
P/S vs Market: The company's P/S indicator (0) is higher than that of the market as a whole (0).
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (0) is higher than that of the sector as a whole (0).
EV/Ebitda vs Market: The company's EV/Ebitda (0) is higher than that of the market as a whole (0).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -20% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-20%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (0%).
5.4. ROE
ROE vs Sector: The company's ROE (0%) is lower than that of the sector as a whole (0%).
ROE vs Market: The company's ROE (0%) is lower than that of the market as a whole (0%).
5.5. ROA
ROA vs Sector: The company's ROA (0%) is lower than that of the sector as a whole (0%).
ROA vs Market: The company's ROA (0%) is lower than that of the market as a whole (0%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (0%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (0%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 4.6% is higher than the average for the sector '0%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 4.6% has been steadily paid over the past 7 years, DSI=0.86.
Weak dividend growth: The company's dividend yield 4.6% has been growing weakly or stagnant over the past 5 years. Growth over only 2 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
